Trends in the development of remdesivir based inventions against COVID-19 and other disorders: A patent review

The development of remdesivir has been a breakthrough for COVID-19 treatment. It has been approved in about 50 countries, including Saudi Arabia, since 2020. The generic structure of remdesivir was first disclosed in 2009. This patent review summarizes the remdesivir based inventions to treat/preven...

Descripción completa

Detalles Bibliográficos
Autores principales: Imran, Mohd., Alshrari, Ahmed Subeh, Asdaq, Syed Mohammed Basheeruddin, Abida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236076/
https://www.ncbi.nlm.nih.gov/pubmed/34243049
http://dx.doi.org/10.1016/j.jiph.2021.06.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236076/
https://www.ncbi.nlm.nih.gov/pubmed/34243049
http://dx.doi.org/10.1016/j.jiph.2021.06.013

Ejemplares similares